Prediction result · Ensemble engineUpdated 6:53 AM

OGNOrganon & Co. stock price outlook

No consensus — 16 of 16 bots holdingThe read comes from 16 independent decision trees that each vote Bull, Bear or Hold from different signals (momentum, trend, valuation, news, risk). The label only calls a direction when a real majority agrees — otherwise it says so honestly.No edge · 0 bull · 0 bear · 16 hold
$13.84+0.22% since prev closeNeutral

Organon & Co. (OGN) is trading at $13.84, up 0.22% since the previous close and +0.65% over the past week. Price sits above its 50-day average by 0.75%, with price momentum at 52/100 and trend velocity at 52/100. Sentiment across 8 recent headlines reads net constructive at 58/100. Volatility risk is contained (4/100) and the stock is 100% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.

Universal leanmarket
OGN

Organon & Co.

$13.84+0.22%
LEANNEUTRAL / wait for cleaner tape
WHY
  • Organon & Co. (OGN) is trading at $13.84, up 0.22% since the previous close and +0.65% over the past week. Price sits above its 50-day average by 0.75%, with price momentum at 52/100 and trend velocity at 52/100. Sentiment across 8 recent headlines reads net constructive at 58/100. Volatility risk is contained (4/100) and the stock is 100% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.
  • Bull input: No bullish case in the sources.
  • Bear input: No bearish case in the sources.
RISK

Signals are model output from public data, not personalized investment advice.

INVALIDATE

Invalidate when a clear catalyst or directional print replaces the mixed tape.

50/100 · Neutral · live · research only

AI Signal

Neutral · No edge

live data

Full public-market mode: chart history, quote, and news inputs were available.

Chart feed

Cron market chart feed

Quote/history

Six-month public chart history loaded.

News feed

8 relevant headlines found.

Signal inputs

Technical factors and news sentiment evaluated across multiple signal inputs.

News Sentiment58/100
Price Momentum52/100
Trend Velocity52/100
Volatility Risk4/100

Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.

Why It Matters

Signal Explanation

Organon & Co. (OGN) is trading at $13.84, up 0.22% since the previous close and +0.65% over the past week. Price sits above its 50-day average by 0.75%, with price momentum at 52/100 and trend velocity at 52/100. Sentiment across 8 recent headlines reads net constructive at 58/100. Volatility risk is contained (4/100) and the stock is 100% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.

Analyst Engine · Specialist model ensemble

Trees disagree — no clear lean on OGN

Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.

Engine edgeNo edgeNeutral
0 bull 16 hold 0 bear
HOLDMomentum + Trend
Inputs: momentum, trendVelocity

Mixed signal: momentum 52/100, trend 52/100.

40% weight
HOLDNews + Price
Inputs: newsSentiment, dayChange

Sentiment 58/100 + price 0.2% are both mid-range.

35% weight
HOLDVolume Breakout
Inputs: unusualVolume, dayChange

Volume read 25/100 with price drift 0.2% — no clear footprint.

30% weight
HOLDVolatility Regime
Inputs: volatilityRisk, momentum

Vol regime 4/100 is mid-range — no edge.

30% weight
HOLDRange Recovery
Inputs: pctOfRange, trendVelocity

Near range top — needs fresh catalyst to break out.

40% weight
HOLDSentiment Lead
Inputs: newsSentiment, weekChange

Sentiment 58/100 vs week change 0.7% are in agreement — no divergence edge.

30% weight
HOLDTrend Structure
Inputs: vsSma50, momentum

Price within 0.8% of the 50d SMA — no clear structural read.

35% weight
HOLDOscillator
Inputs: momentum, trendVelocity

Oscillator at 52 — neutral zone.

30% weight
HOLDMomentum Breakout
Inputs: momentum, dayChange, vsSma50

Momentum 52/100 is not strong enough to confirm a breakout.

35% weight
HOLDNews Follow-Through
Inputs: newsSentiment, weekChange

News 58/100 and weekly change 0.7% do not create a clean follow-through read.

30% weight
HOLDVolume Dry-Up
Inputs: unusualVolume, trendVelocity

Volume 25/100 does not show a dry-up signal.

28% weight
HOLDVolatility Compression
Inputs: volatilityRisk, pctOfRange, momentum

Volatility 4/100 does not give a clean compression read.

30% weight
HOLDRange Breakout
Inputs: pctOfRange, dayChange, weekChange

Range position 100% is too middle-of-the-road to matter.

30% weight
HOLDSentiment + Momentum
Inputs: newsSentiment, momentum, weekChange

Sentiment 58/100 and momentum 52/100 are not aligned enough for a clean read.

32% weight
HOLDMA Reclaim
Inputs: vsSma50, momentum, trendVelocity

50d SMA distance 0.8% is not decisive.

30% weight
HOLDOscillator Rebound
Inputs: momentum, trendVelocity, weekChange

Oscillator at 52 does not show a rebound edge.

30% weight

Why the ensemble agrees

  • Mixed signal: momentum 52/100, trend 52/100.
  • Near range top — needs fresh catalyst to break out.
  • Sentiment 58/100 + price 0.2% are both mid-range.

Bull Case

  • No bullish case in the sources.

Bear Case

  • No bearish case in the sources.

Key stats

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Market cap
$3.63B
52-week range
$13.83/$5.69
Volume
1,848,197
Analyst 1-yr target
$9.00
Exchange
NYSE

Source: Nasdaq public quote data. Research only.

Earnings Intelligence

Next

Nov 9, 2026

Estimate

$0.95

Actual

$0.8

  • • Last report Jul 31, 2026 (Jun 2026): EPS $0.8 vs $0.85 expected, -5.88% surprise.
  • • Beat estimates in 1 of the last 4 quarters.
  • • Next report expected Nov 9, 2026, consensus EPS $0.95 (Zacks estimate via Nasdaq; the company may confirm a different date).

Risk Warnings

  • • Signals are model output from public data, not personalized investment advice.
  • • Markets can move against any signal regardless of the score.
  • • Confirm liquidity, spreads, and your own thesis before acting.

OGN questions

What is the MarketPicks AI signal for Organon & Co. stock (OGN)?

As of Nov 2, 1:53 AM ET, the ensemble reads neutral on OGN — no consensus — 16 of 16 bots holding, with 0 bull, 0 bear and 16 hold votes from 16 specialist bots. Research only, not investment advice.

What is the latest OGN price on MarketPicks?

OGN was $13.84 on the latest quote (Nov 2, 1:53 AM ET), +0.22% since the previous close. Quotes can be delayed.

What do the momentum and trend scores for OGN mean?

Scores run from 0 to 100, with 50 neutral. OGN shows momentum 52/100, trend velocity 52/100 and volatility risk 4/100, with news sentiment at 58/100.

Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.

Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.